Physician profile
Jeffrey Eric Levy
NPI 1306880497
$522.04
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $177 · 2020: $44.68 · 2021: $86.78 · 2022: $99.22 · 2023: $25.86 · 2024: $88.78.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $115.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $114.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $99.91 | 2021-2024 | Aveir |
| Ironshore Pharmaceuticals INC. | $74.00 | 2019-2020 | |
| Glaxosmithkline, LLC. | $61.04 | 2019 | |
| Cranial Technologies, INC | $58.34 | 2019-2022 | |
| Tris Pharma INC | $55.89 | 2021-2022 | |
| Aytu Biopharma, INC. | $46.55 | 2021-2022 | |
| Boston Scientific Corporation | $43.49 | 2019 | |
| Kaleo, INC. | $27.86 | 2021-2022 | |
| Supernus Pharmaceuticals, INC. | $27.44 | 2021-2023 | Qelbree |
| Sanofi Pasteur INC. | $14.53 | 2019 | |
| Phadia US INC. | $12.99 | 2023 | Immunocap |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Levy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.